| Price | Lot Size | Issue Date | Issue Size |
|---|---|---|---|
| ₹154 to ₹162 | 92 | 10th Dec, 2025 –12th Dec, 2025 | ₹920.00 Cr |
Park Medi World Ltd
The company is the second-largest private hospital chain in North India, with a total bed capacity of 3,000, and the largest in Haryana, operating 1,600 beds in the state as of March 31, 2025. Its network comprises 14 NABH-accredited multispecialty hospitals under the ‘Park’ brand across Haryana, Delhi, Punjab, and Rajasthan, offering more than 30 specialty and super-specialty services, including internal medicine, neurology, urology, gastroenterology, orthopedics, and oncology. As of September 30, 2025, the organization employs over 1,000 doctors and 2,100 nurses dedicated to delivering high-quality clinical care. Founded by Dr. Ajit Gupta, who established the Park Hospital brand in 2005, the company has grown significantly through strategic expansions and the acquisition of eight hospitals across North India, increasing its bed capacity from 2,550 to 3,250 within two years. Its expansion pipeline includes new projects in Ambala, Panchkula, Rohtak, Gorakhpur, and Kanpur, with a projected increase in total capacity to 4,900 beds by 2028. The company is also in the process of acquiring Durha Vitrak (Febris Multi-Specialty Hospital, New Delhi) and has a long-term agreement to operate a 400-bed hospital in Gorakhpur. Its hospitals are equipped with advanced clinical infrastructure, including 870 ICU beds, 67 operating theatres, dedicated cancer units with linear accelerators, and specialized Institutes for Minimal Access and Robotic Surgery (iMARS).
Objective of the Park Medi World Ltd IPO
Out of the total issue size of Rs. 920 crores, Rs. 150 crores comprises OFS.
The company proposes to utilize net proceeds from the issue towards the following objects:
- Repayment/ prepayment, in full or in part, of outstanding borrowings availed by company and Subsidiaries;
- Funding capital expenditure for development of new hospital by Subsidiary, Park Medicity (NCR);
- Funding capital expenditure for purchase of medical equipment by company and Subsidiaries, Blue Heavens and Ratangiri; and
- Unidentified inorganic acquisitions and general corporate purposes.
Rationale To Park Medi World Ltd IPO
North India’s second-largest private hospital chain, anchored by Haryana market leadership
The company’s position as the second-largest private hospital chain in North India and the largest in Haryana provides a strong foundation for sustainable long-term growth. With an aggregate bed capacity rising from 2,550 beds in FY23 to 3,250 beds as of September 30, 2025, the company has demonstrated consistent expansion through a combination of organic growth and strategic acquisitions. Its cluster-based approach, establishing hospitals in adjacent geographies, has enabled brand reinforcement, resource sharing, and meaningful operating leverage. The network today comprises 14 NABH-accredited multi-super specialty hospitals equipped with 870 ICU beds, 67 operating theatres, dedicated cancer units, trauma centers, and oxygen generation plants, underscoring strong clinical infrastructure and capability. Five hospitals are also approved for kidney transplant procedures, reflecting competency in high-acuity care. With operations concentrated in North India, a region characterized by significant under-penetration of healthcare infrastructure and low doctor, nurse, and bed availability, the company is strategically positioned to capture a disproportionate share of regional demand. Supported by favorable industry tailwinds, including rising demand for routine and elective procedures and a healthcare delivery market projected to grow at a 10-12% CAGR through FY29, the company stands to benefit from scale, brand strength, and increasing demand for quality yet affordable healthcare. The company’s entrenched leadership in North India provides a strategic platform to tap into sizeable market opportunities and drive scale efficiencies, all while preserving the quality standards central to its healthcare delivery model.
High-quality, affordable healthcare across a diverse specialty network
The company operates with a clear vision of delivering high-quality healthcare at affordable rates, primarily serving lower- and middle-income patients across its extensive hospital network. Its focus on affordability is supported by disciplined cost optimization measures, including the use of advanced medical technologies that shorten patient recovery times, a predominantly full-time clinical workforce, strong vendor partnerships, and the operating leverage generated from its growing regional footprint. The company has further enhanced its clinical capabilities by deploying its advanced iMARS robotic surgery system across three hospitals, enabling minimally invasive procedures that deliver improved accuracy, reduced discomfort, quicker recovery, and better patient outcomes. Alongside robotic surgery, it offers a broad range of complex interventions, including angioplasty, non-surgical valve replacements, leadless pacemakers, bariatric surgery, stroke care, and kidney transplants, strengthening both clinical depth and efficiency. Overall, the company derives its revenue from a broad portfolio of specialties, enabling sustained business growth while mitigating concentration risks across its operations. As of September 30, 2025, it offered more than 30 super-specialty and specialty services across its hospital network.
Valuation of Park Medi World Ltd IPO
Park Medi World Limited is the second-largest private hospital chain in North India with a capacity of 3,000 beds, and the largest operator in Haryana with 1,600 beds as of March 31, 2025. The company operates 14 NABH-accredited multispecialty hospitals, offering 30+ specialties, including neurology, urology, gastroenterology, orthopedics, general surgery, and oncology. Its network is supported by a substantial clinical workforce of 1,014 doctors and 2,142 nurses as of September 30, 2025. The company’s business model focuses on affordable, high-quality healthcare delivery in fast-growing Tier-II North Indian markets, giving it a strong regional scale advantage. The company is positioned to leverage the structural expansion of healthcare demand in North India. Park Medi has built its footprint through a combination of organic expansion and targeted acquisitions, as seen in its diversified subsidiary network across Haryana, Delhi, Punjab, and Rajasthan. The group continues to invest heavily in physical infrastructure; this capex-led strategy supports bed additions, new specialties, and capacity upgrades. India’s healthcare delivery sector continues to benefit from strong macro tailwinds. North India, in particular, remains underpenetrated in hospital beds relative to national averages, creating a long runway for private operators. On the financial front, the company has demonstrated Revenue CAGR growth of 5.4% between FY23 and FY25, led by the rapid expansion of its hospital network, both organically and through the acquisition of multiple operating subsidiaries across Haryana, Delhi NCR, Punjab, and Rajasthan. Overall, the company’s growth outlook is underpinned by network expansion via brownfield and greenfield projects, deeper penetration of high-margin specialties, and operating leverage from maturing hospitals. At the upper end of the price band at Rs. 162, the company is valued at a P/E multiple of 29.2x FY25 earnings. We, thus, recommend a “SUBSCRIBE” rating for this issue.
What is the Park Medi World Ltd IPO?
The initial public offer (IPO) of Park Medi World Ltd offers an early investment opportunity in Park Medi World Ltd . A stock market investor can buy Park Medi World Ltd IPO shares by applying in IPO before All Park Medi World Ltd shares get listed at the stock exchanges. An investor could invest in Park Medi World Ltd IPO for short term listing gain or a long term.
How to apply for the Park Medi World Ltd IPO through StoxBox?
To apply for the Park Medi World Ltd IPO through StoxBox one can apply from the website and also from the app. Click here
When will the Park Medi World Ltd IPO open?
Park Medi World Ltd IPO is opening on 10th Dec 2025. Apply Now
What is the lot size of the Park Medi World Ltd IPO?
The Lot Size of Park Medi World Ltd IPO is 92 equity shares. Login to your account now.
When is the Park Medi World Ltd allotment date?
The allotment Date for Park Medi World Ltd IPO is 15th Dec 2025. Login to your account now.
When is the Park Medi World Ltd IPO listing date?
The listing Date for Park Medi World Ltd IPO is 17th Dec 2025. Login to your account now
What is the minimum investment required for the Park Medi World Ltd IPO?
In the Retail segment the minimum investment required is Rs. 14,904. Login to your account now
What is the maximum investment allowed for the Park Medi World Ltd IPO?
In the Retail segment the maximum investment requirement is Rs. 1,93,752. Login to your account now
What are the risks associated with investing in the Corona Remedies Ltd IPO?
- The company’s substantial revenue is derived from women’s healthcare, cardiovascular-diabetes, and pain management, accounting for 65.1% of Q1FY26 revenue. Any underperformance of products in these segments, or increased competition, could materially impact the company’s revenue, profitability, and cash flows.
- The company’s 27 engine brands contribute 72.34% of domestic sales (MAT Jun’ 25), with significant reliance on key brands such as B-29 and Myoril. Any adverse developments impacting the performance, market acceptance or competitive positioning of these core brands could materially affect the company’s business, financial performance and cash flows.
- The company’s domestic sales exhibit a high regional concentration, with Gujarat, Maharashtra, Chhattisgarh, Goa, and Madhya Pradesh collectively accounting for 47.30% of MAT Jun ’25 revenues. This concentration heightens exposure to region-specific disruptions, including regulatory actions, competitive intensification, supply-chain constraints, which could materially affect sales traction in these key markets and, in turn, weigh on the overall business performance, financial outcomes and cash flow stability.
When will the Park Medi World Ltd IPO shares be credited to my Demat account?
The Park Medi World Ltd IPO be credited to the account on allotment date which is 15th Dec 2025. Login to your account now
Where can I find the Park Medi World Ltd IPO prospectus?
The prospectus of Park Medi World Ltd IPO prospectus can be find on the website of SEBI, NSE and BSE
